NORDIC PHARMACEUTICALS ApS: Financial statements 2024
CVR: 27430015
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
NORDIC PHARMACEUTICALS ApS (CVR 27430015) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -2,243,265 and a net result of DKK -2,664,416 compared with DKK 9,351 the year before. Equity in the 2024 report amounted to DKK -1,152,541. The company had 2 employees in the financial year.
- Gross Profit
- DKK -2,243,265
- Profit/Loss
- DKK -2,664,416
- Equity
- DKK -1,152,541
- Total Assets
- DKK 22,117
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -2.2M | -2.7M | -1.2M | 2 |
| 2023 | - | 552K | 9K | 1.5M | 2 |
| 2022 | - | 779K | 84K | 1.5M | 2 |
| 2021 | - | 653K | 71K | 1.4M | 2 |
| 2020 | - | 602K | 58K | 1.3M | 3 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
NORDIC PHARMACEUTICALS ApS has published its annual report for 2023. Gross profit came to DKK 551,900, and the net result was DKK 9,351.
About NORDIC PHARMACEUTICALS ApS
NORDIC PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Hvidovre, founded in 2003. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The management consists of Lars Bo Holløse Nielsen. The board consists of Knud Benny Junge (chair). The company is owned by Lars Bo Holløse Nielsen and Kea Ok Junge. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -165,886 and a net result of DKK -573,072 compared with DKK -2,664,416 the year before. Equity in the 2025 report amounted to DKK -1,725,613.